Other prostate cancer cell lines were evaluated but found unsuitable for this study: DU-145 and PC-3 lack PSMA expression, PC-3 PIP cells express artificially high levels of PSMA, and LNCaP cells showed poor tolerance to the experimental procedures, resulting in substantial cell loss. This evidence concerns the gene FOLH1 and prostate cancer.